Bioventus
Bioventus develops innovations in pain treatment, restorative therapies, and surgical solutions to help patients resume active lives. Learn more
Launch date
Employees
Market cap
€662m
Enterprise valuation
€982m (Public information from Sep 2024)
Share price
$11.59 BVS
Durham North Carolina (HQ)
Authorizing premium user...